Clascoterone for Steroid-related Acne Vulgaris in Transgender Male Patients Receiving Masculinizing Hormone Therapy
Condition: Acne Vulgaris Interventions: Drug: Clascoterone 1% Top Cream; Drug: Vehicle Sponsor: Stanford University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials